Additionally, we found that EGFR-mutant and ALK-rearranged NSCLC showed a different intratumoral immune profile than other tumors, characterized by a lack of CD8+ and activated memory CD4+ T cells, as well as an enrichment of resting memory CD4+ T cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.